89
Views
6
CrossRef citations to date
0
Altmetric
Special Report

Assessment of vision-related quality of life measures in ophthalmic conditions

&
Pages 691-724 | Published online: 09 Jan 2014

References

  • Steinberg EP, Tielsch JM, Schein OD et al. National study of cataract surgery outcomes. Variation in 4-month postoperative outcomes as reflected in multiple outcome measures. Ophthalmology101(6), 1131–1140 (1994).
  • Mangione CM, Russell SP, Lawrence MG, Seddon JM, Orav EJ, Goldman L. Improved visual function and attenuation of declines in vision-related quality of life after cataract extraction. Arch. Ophthalmol.112(11), 1419–1425 (1994).
  • Lundström M, Stenevi U, Thorburn W, Roos P. Catquest questionnaire for use in cataract surgery care: assessment of surgical outcomes. J. Cataract Refract. Surg.24(7), 968–974 (1998).
  • Lundström M, Stenevi U, Thorburn W. Cataract surgery in the very elderly. J. Cataract Refract. Surg.26(3), 408–414 (2000).
  • Mönestam E, Wachmeister L. Impact of cataract surgery on the visual ability of the very old. Am. J. Ophthalmol.137(1), 145–155 (2004).
  • Elliott DB, Patla AE, Furniss M, Adkin A. Improvements in clinical and functional vision and quality of life after second eye cataract surgery. Optom. Vis. Sci.77(1), 13–24 (2000).
  • Lundström M, Stenevi U, Thorburn W. Quality of life after first- and second-eye cataract surgery: five-year data collected by the Swedish National Cataract Register. J. Cataract Refract. Surg.27(10), 1553–1559 (2001).
  • Lundström M, Albrecht S, Nilsson M, Åström B. Benefit to patients of bilateral same-day cataract extraction: randomized clinical study. J. Cataract Refract. Surg.32(5), 826–830 (2006).
  • Lundström M, Brege KG, Florén I, Lundh B, Stenevi U, Thorburn W. Cataract surgery and quality of life in patients with age-related macular degeneration. Br. J. Ophthalmol.86(12), 1330–1335 (2002).
  • Pham TQ, Cugati S, Rochtchina E, Mitchell P, Maloof A, Wang JJ. Age-related maculopathy and cataract surgery outcomes: visual acuity and vision-related quality of life. Eye Nov 11 (2005) (Epub ahead of print).
  • Armbrecht AM, Findlay C, Aspinall PA, Hill AR, Dhillon B. Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J. Cataract Refract. Surg.29(4), 686–693 (2003).
  • Lundström M, Brege KG, Florén I, Stenevi U, Thorburn W. Impaired visual function after cataract surgery assessed using the Catquest questionnaire. J. Cataract Refract. Surg.26, 101–108 (2000).
  • Lundström M, Brege KG, Florén I, Stenevi U, Thorburn W. Strategy to reduce the number of patients perceiving impaired visual function after cataract surgery. J. Cataract Refract. Surg.28(6), 971–976 (2002).
  • Lundström M, Wendel E. Duration of self-assessed benefit of cataract extraction: a long-term study. Br. J. Ophthalmol.89(8), 1017–1020 (2005).
  • Bellan L. Why are patients with no visual symptoms on cataract waiting lists? Can. J. Ophthalmol.40(4), 433–438 (2005).
  • Malik R, Frost NA, Sparrow JM, Hale L. The Bristol cataract listing survey: profile of listed patients with visual acuity 6/12 or better. Eye19(4), 406–410 (2005).
  • Wright CJ, Chambers GK, Robens-Paradise Y. Evaluation of indications for and outcomes of elective surgery. CMAJ167(5), 461–466 (2002).
  • Pager CK, McCluskey PJ, Retsas C. Cataract surgery in Australia: a profile of patient-centred outcomes. Clin. Experiment. Ophthalmol.32(4), 388–392 (2004).
  • Espindle D, Crawford B, Maxwell A et al. Quality-of-life improvements in cataract patients with bilateral blue light-filtering intraocular lenses: clinical trial. J. Cataract Refract. Surg.31(10), 1952–1959 (2005).
  • Brydon KW, Tokarewicz AC, Nichols BD. AMO array multifocal lens versus monofocal correction in cataract surgery. J. Cataract Refract. Surg.26(1), 96–100 (2000).
  • Tinley CG, Frost A, Hakin KN, McDermott W, Ewings P. Is visual outcome compromised when next day review is omitted after phacoemulsification surgery? A randomised control trial. Br. J. Ophthalmol.87(11), 1350–1355 (2003).
  • Lau J, Michon JJ, Chan WS, Ellwein LB. Visual acuity and quality of life outcomes in cataract surgery patients in Hong Kong. Br. J. Ophthalmol.86(1), 12–17 (2002).
  • Mozaffarieh M, Heinzl H, Sacu S, Wedrich A. Clinical outcomes of phacoemulsification cataract surgery in diabetes patients: visual function (VF-14), visual acuity and patient satisfaction. Acta Ophthalmol. Scand.83(2), 176–183 (2005).
  • Pager CK. Expectations and outcomes in cataract surgery: a prospective test of 2 models of satisfaction. Arch. Ophthalmol.122(12), 1788–1792 (2004).
  • Stifter E, Sacu S, Weghaupt H. Functional vision with cataracts of different morphologies: comparative study. J. Cataract Refract. Surg.30(9), 1883–1891 (2004).
  • Pomberg ML, Miller KM. Functional visual outcomes of cataract extraction in monocular versus binocular patients. Am. J. Ophthalmol.138(1), 125–132 (2004).
  • Norregaard JC, Bernth-Petersen P, Alonso J, Andersen TF, Anderson GF. Visual functional outcomes of cataract surgery in the United States, Canada, Denmark, and Spain: report of the International Cataract Surgery Outcomes Study. J. Cataract Refract. Surg.29(11), 2135–2142 (2003).
  • Javitt JC, Schiffman RM. Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular hypertension: a randomized clinical trial. Brimonidine Outcomes Study Group I. J. Glaucoma9(3), 224–234 (2000).
  • Cantor LB, Hoop J, Katz LJ, Flartey K (Alphagan/Betaxolol Clinical Success Study Group). Comparison of the clinical success and quality-of-life impact of brimonidine 0.2% and betaxolol 0.25% suspension in patients with elevated intraocular pressure. Clin. Ther.23(7), 1032–1039 (2001).
  • Montemayor F, Sibley LM, Courtright P, Mikelberg FS. Contribution of multiple glaucoma medications to visual function and quality of life in patients with glaucoma. Can. J. Ophthalmol.36(7), 385–390 (2001).
  • Nordmann J-P, Auzanneau N, Ricard S, Berdeaux G. Vision related quality of life and topical glaucoma treatment side effects. Health Qual. Life Outcomes1(1), 75 (2003).
  • Janz NK, Wren PA, Lichter PR, Musch DC, Gillespie BW, Guire KE. Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study. Ophthalmology108(5), 887–898 (2001).
  • Janz NK, Wren PA, Lichter PR et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology108(11), 1954–1965 (2001).
  • Balkrishnan R, Bond JB, Byerly WG, Camacho FT, Anderson RT. Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization. Am. J. Geriatr. Pharmacother.1(2), 75–81 (2003).
  • Hyman LG, Komaroff E, Heijl A, Bengtsson B, Leske MC (Early Manifest Glaucoma Trial Group). Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology112(9), 1505–1513 (2005).
  • Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest. Ophthalmol. Vis. Sci.43(4), 1059–1067 (2002).
  • Mills RP, Janz NK, Wren PA, Guire KE. Correlation of visual field with quality-of-life measurements at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J. Glaucoma10(3), 192–198 (2001).
  • Sloan ME, Ball K, Owsley C, Bruni SR, Roenkar DL. The Visual Activities Questionnaire: developing an instrument for assessing problems in everyday visual tasks. Tech. Dig. (Opt. Soc. Am.)1, 26–29 (1992).
  • Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am. J. Ophthalmol.141(1 Suppl.), S3–S14 (2006).
  • Berdeaux GH, Nordmann JP, Colin E, Arnould B. Vision-related quality of life in patients suffering from age-related macular degeneration. Am. J. Ophthalmol.139(2), 271–279 (2005).
  • Cahill MT, Banks AD, Stinnett SS, Toth CA. Vision-related quality of life in patients with bilateral severe age-related macular degeneration. Ophthalmology112(1), 152–158 (2005).
  • Scilley K, Jackson GR, Cideciyan AV, Maguire MG, Jacobson SG, Owsley C. Early age-related maculopathy and self-reported visual difficulty in daily life. Ophthalmology109(7), 1235–1242 (2002).
  • Maguire M (Complications of Age-Related Macular Degeneration Prevention Trial Research Group). Baseline characteristics, the 25-item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT). Ophthalmology111(7), 1307–1316 (2004).
  • Decarlo DK, Scilley K, Wells J, Owsley C. Driving habits and health-related quality of life in patients with age-related maculopathy. Optom. Vis. Sci.80(3), 207–213 (2003).
  • Brody BL, Roch-Levecq A-C, Thomas RG, Kaplan RM, Brown SI. Self-management of age-related macular degeneration at the 6-month follow-up: a randomized controlled trial. Arch. Ophthalmol.123(1), 46–53 (2005).
  • Reeves BC, Harper RA, Russell WB. Enhanced low vision rehabilitation for people with age related macular degeneration: a randomised controlled trial. Br. J. Ophthalmol.88(11), 1443–1449 (2004).
  • Dong LM, Childs AL, Mangione CM et al. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4. Am. J. Ophthalmol.138(1), 91–108 (2004).
  • Submacular Surgery Trials Research Group. Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials Report No. 5. Arch. Ophthalmol.123(1), 78–88 (2005).
  • Armbrecht AM, Aspinall PA, Dhillon B. A prospective study of visual function and quality of life following PDT in patients with wet age related macular degeneration. Br. J. Ophthalmol.88(10), 1270–1273 (2004).
  • Krummenauer F, Braun M, Dick HB. Clinical outcome and subjective quality of life after photodynamic therapy in patients with age-related macular degeneration. Eur. J. Ophthalmol.15(1), 74–80 (2005).
  • Hewitt AW, Jeganathan VS, Kidd JE, Pesudovs K, Verma N. Influence of photodynamic therapy for age related macular degeneration upon subjective vision related quality of life. Graefes. Arch. Clin. Exp. Ophthalmol.244(8), 972–977 (2006).
  • Stevenson MR, Hart PM, Chakravarthy U et al. Visual functioning and quality of life in the Subfoveal Radiotherapy Study (SFRADS): SFRADS report 2. Br. J. Ophthalmol.89(8), 1045–1051 (2005).
  • Hawkins BS, Miskala PH, Bass EB et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. Arch. Ophthalmol.122(11), 1616–1628 (2004).
  • Childs AL, Bressler NM, Bass EB et al. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: quality-of-life findings: SST report no. 14. Ophthalmology111(11), 2007–2014 (2004).
  • Miskala PH, Bass EB, Bressler NM et al. Surgery for subfoveal choroidal neovascularization in age-related macular degeneration: quality-of-life findings: SST report no. 12. Ophthalmology111(11), 1981–1992 (2004).
  • Cahill MT, Stinnett SS, Banks AD, Freedman SF, Toth CA. Quality of life after macular translocation with 360 degrees peripheral retinectomy for age-related macular degeneration. Ophthalmology112(1), 144–151 (2005).
  • Hazel CA, Petre KL, Armstrong RA, Benson MT, Frost NA. Visual function and subjective quality of life compared in subjects with acquired macular disease. Invest. Ophthalmol. Vis. Sci.41(6), 1309–1315 (2000).
  • Brody BL, Gamst AC, Williams RA et al. Depression, visual acuity, comorbidity, and disability associated with age-related macular degeneration. Ophthalmology108(10), 1893–1900; discussion 900–901 (2001).
  • Tranos PG, Ghazi-Nouri SMS, Rubin GS, Adams ZC, Charteris DG. Visual function and subjective perception of visual ability after macular hole surgery. Am. J. Ophthalmol.138(6), 995–1002 (2004).
  • Nichols JJ, Twa MD, Mitchell GL. Sensitivity of the National Eye Institute Refractive Error Quality of Life instrument to refractive surgery outcomes. J. Cataract Refract. Surg.31(12), 2313–2318 (2005).
  • Garamendi E, Pesudovs K, Elliott DB. Changes in quality of life after laser in situ keratomileusis for myopia. J. Cataract Refract. Surg.31(8), 1537–1543 (2005).
  • Rose K, Harper R, Tromans C et al. Quality of life in myopia. Br. J. Ophthalmol.84(9), 1031–1034 (2000).
  • Schein OD, Vitale S, Cassard SD, Steinberg EP. Patient outcomes of refractive surgery: the refractive status and vision profile. J. Cataract Refract. Surg.27(5), 665–673 (2001).
  • Savage H, Rothstein M, Davuluri G, El Ghormli L, Zaetta DM. Myopic astigmatism and presbyopia trial. Am. J. Ophthalmol.135(5), 628–632 (2003).
  • Lipson MJ, Sugar A, Musch DC. Overnight corneal reshaping versus soft daily wear: a visual quality of life study (interim results). Eye Contact Lens30(4), 214–217; discussion 218 (2004).
  • Lipson MJ, Sugar A, Musch DC. Overnight corneal reshaping versus soft disposable contact lenses: vision-related quality-of-life differences from a randomized clinical trial. Optom. Vis. Sci.82(10), 886–891 (2005).
  • Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire. J. Allergy Clin. Immunol.104(2 Pt 1), 364–369 (1999).
  • Alexander M, Allegro S, Hicks A. Efficacy and acceptability of nedocromil sodium 2% and olopatadine hydrochloride 0.1% in perennial allergic conjunctivitis. Adv. Ther.17(3), 140–147 (2000).
  • Lanier BQ, Gross RD, Marks BB, Cockrum PC, Juniper EF. Olopatadine ophthalmic solution adjunctive to loratadine compared with loratadine alone in patients with active seasonal allergic conjunctivitis symptoms. Ann. Allergy Asthma Immunol.86(6), 641–648 (2001).
  • Bousquet J, Lund VJ, van Cauwenberge P et al. Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial. Allergy58(8), 733–741 (2003).
  • Berger W, Abelson MB, Gomes PJ et al. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Ann. Allergy Asthma Immunol.95(4), 361–371 (2005).
  • Mangione CM, Lee PP, Gutierrez PR et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch. Ophthalmol.119(7), 1050–1058 (2001).
  • Klein R, Moss SE, Klein BEK, Gutierrez P, Mangione CM. The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch. Ophthalmol.119(5), 733–740 (2001).
  • Tranos PG, Topouzis F, Stangos NT et al. Effect of laser photocoagulation treatment for diabetic macular oedema on patient’s vision-related quality of life. Curr. Eye Res.29(1), 41–49 (2004).
  • Leksell JK, Sandberg GE, Wikblad KF. Self-perceived health and self-care among diabetic subjects with defective vision: a comparison between subjects with threat of blindness and blind subjects. J. Diabetes Complications19(1), 54–59 (2005).
  • Sharma S, Oliver-Fernandez A, Liu W, Buchholz P, Walt J. The impact of diabetic retinopathy on health-related quality of life. Curr. Opin. Ophthalmol.16(3), 155–159 (2005).
  • Boisjoly H, Gresset J, Charest M et al. The VF-14 index of visual function in recipients of a corneal graft: a 2-year follow-up study. Am. J. Ophthalmol.134(2), 166–171 (2002).
  • Saunders PPR, Sibley LM, Richards JSF, Chow DL, Courtright P. Outcome of corneal transplantation: can a prioritisation system predict outcome? Br. J. Ophthalmol.86(1), 57–61 (2002).
  • Weih L, McCarty CA, Taylor HR. Functional implications of vision impairment. Clin. Experiment. Ophthalmol.28(3), 153–155 (2000).
  • Tanriverdi N, Taskintuna I, Dürü C, Ozdal P, Ortac S, Firat E. Health-related quality of life in Behcet patients with ocular involvement. Jpn J. Ophthalmol.47(1), 85–92 (2003).
  • Mozaffarieh M, Krepler K, Heinzl H, Sacu S, Wedrich A. Visual function, quality of life and patient satisfaction after ophthalmic surgery: a comparative study. Ophthalmologica218(1), 26–30 (2004).
  • Chabert S, Velikay-Parel M, Zehetmayer M. Influence of uveal melanoma therapy on patients’ quality of life: a psychological study. Acta Ophthalmol. Scand.82(1), 25–31 (2004).
  • Brandberg Y, Damato B, Kivela T et al. The EORTC ophthalmic oncology quality of life questionnaire module (EORTC QLQ-OPT30). Development and pre-testing (Phase I-III). Eye18(3), 283–289 (2004).
  • Sundelin K, Lundström M, Stenevi U. Self-assessed visual function for patients with posterior capsule opacification before and after capsulotomy. Acta Ophthalmol. Scand.83(6), 729–733 (2005).
  • Kafil-Hussain N, Khooshebah R. Clinical research, comparison of the subjective visual function in patients with epiphora and patients with second-eye cataract. Orbit24(1), 33–38 (2005).
  • Balcer LJ, Baier ML, Kunkle AM et al. Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25). Mult. Scler.6(6), 382–385 (2000).
  • Kuang TM, Hsu WM, Chou CK, Tsai SY, Chou P. Impact of stereopsis on quality of life. Eye19(5), 540–545 (2005).
  • Pilling RF, Thompson JR, Gottlob I. Social and visual function in nystagmus. Br. J. Ophthalmol.89(10), 1278–1281 (2005).
  • Berry S, Mangione CM, Lindblad AS, McDonnell PJ. Development of the National Eye Institute refractive error correction quality of life questionnaire: focus groups. Ophthalmology110(12), 2285–2291 (2003).
  • Hays RD, Mangione CM, Ellwein L, Lindblad AS, Spritzer KL, McDonnell PJ. Psychometric properties of the National Eye Institute-Refractive Error Quality of Life instrument. Ophthalmology110(12), 2292–2301 (2003).
  • McDonnell PJ, Mangione C, Lee P et al. Responsiveness of the National Eye Institute Refractive Error Quality of Life instrument to surgical correction of refractive error. Ophthalmology110(12), 2302–2309 (2003).
  • Kymes SM, Walline JJ, Zadnik K, Gordon MO (Collaborative Longitudinal Evaluation of Keratoconus study group). Quality of life in keratoconus. Am. J. Ophthalmol.138(4), 527–535 (2004).
  • Hall TA, McGwin G Jr, Searcey K et al. Health-related quality of life and psychosocial characteristics of patients with benign essential blepharospasm. Arch. Ophthalmol.124(1), 116–169 (2006).
  • Reimer J, Gilg K, Karow A, Esser J, Franke GH. Health-related quality of life in blepharospasm or hemifacial spasm. Acta Neurol. Scand.111(1), 64–70 (2005).
  • Schiffman RM, Jacobsen G, Whitcup SM. Visual functioning and general health status in patients with uveitis. Arch. Ophthalmol.119(6), 841–849 (2001).
  • Burstedt MS, Monestam E, Sandgren O. Associations between specific measures of vision and vision-related quality of life in patients with Bothnia dystrophy, a defined type of retinitis pigmentosa. Retina25(3), 317–323 (2005).
  • Frost A, Eachus J, Sparrow J et al. Vision-related quality of life impairment in an elderly UK population: associations with age, sex, social class and material deprivation. Eye15(Pt 6), 739–744 (2001).
  • Broman AT, Munoz B, Rodriguez J et al. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest. Ophthalmol. Vis. Sci.43(11), 3393–3398 (2002).
  • Globe DR, Varma R, Torres M, Wu J, Klein R, Azen SP; Los Angeles Latino Eye Study Group. Self-reported comorbidities and visual function in a population-based study: the Los Angeles Latino Eye Study. Arch. Ophthalmol.123(6), 815–821 (2005).
  • Chia E-M, Mitchell P, Rochtchina E, Foran S, Wang JJ. Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study. Br. J. Ophthalmol.87(4), 392–395 (2003).
  • Chia E-M, Wang JJ, Rochtchina E, Smith W, Cumming RR, Mitchell P. Impact of bilateral visual impairment on vision-related quality of life: the Blue Mountains Eye Study. Invest. Ophthalmol. Vis. Sci.45(1), 71–76 (2004).
  • Knudtson MD, Klein BE, Klein R, Cruickshanks KJ, Lee KE. Age-related eye disease, quality of life, and functional activity. Arch. Ophthalmol.123(6), 807–814 (2005).
  • Nirmalan PK, Tielsch JM, Katz J et al. Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: the Aravind Comprehensive Eye Survey. Invest. Ophthalmol. Vis. Sci.46(7), 2308–2312 (2005).
  • Tsai SY, Chi LY, Cheng CY, Hsu WM, Liu JH, Chou P. The impact of visual impairment and use of eye services on health-related quality of life among the elderly in Taiwan: the Shihpai Eye Study. Qual. Life Res.13(8), 1415–1424 (2004).
  • Steinberg EP, Tielsch JM, Schein OD et al. The VF-14. An index of functional impairment in patients with cataract. Arch. Ophthalmol.112(5), 630–638 (1994).
  • Lee JE, Fos PJ, Zuniga MA, Kastl PR, Sung JH. Assessing health-related quality of life in cataract patients: the relationship between utility and health-related quality of life measurement. Qual. Life Res.9(10), 1127–1135 (2000).
  • Velozo CA, Lai JS, Mallinson T, Hauselman E. Maintaining instrument quality while reducing items: application of Rasch analysis to a self-report of visual function. J. Outcome Meas.4(3), 667–680 (2000).
  • Mallinson T, Stelmack J, Velozo C. A comparison of the separation ratio and coefficient alpha in the creation of minimum item sets. Med. Care42(1 Suppl. 1), 117–124 (2004).
  • Friedman DS, Tielsch JM, Vitale S, Bass EB, Schein OD, Steinberg EP. VF-14 item specific responses in patients undergoing first eye cataract surgery: can the length of the VF-14 be reduced? Br. J. Ophthalmol.86(8), 885–891 (2002).
  • Lee JE, Fos PJ, Zuniga MA, Kastl PR, Sung JH. Vision-related quality of life of cataract patients: cross-cultural comparisons of utility and psychometric measures. Ophthalmic. Epidemiol.10(3), 177–191 (2003).
  • Dam OM, Sibley LM, Law FC, Lui L, Le G, Courtright P. Reliability and reproducibility of a Chinese-language visual function assessment. Ophthalmic Epidemiol.8(5), 327–337 (2001).
  • Pager CK. Assessment of visual satisfaction and function after cataract surgery. J. Cataract Refract. Surg.30(12), 2510–2516 (2004).
  • Uusitalo RJ, Brans T, Pessi T, Tarkkanen A. Evaluating cataract surgery gains by assessing patients' quality of life using the VF-7. J. Cataract Refract. Surg.25(7), 989–994 (1999).
  • Rosen PN, Kaplan RM, David K. Measuring outcomes of cataract surgery using the Quality of Well-Being Scale and VF-14 Visual Function Index. J. Cataract Refract. Surg.31(2), 369–378 (2005).
  • Mackenzie PJ, Chang TS, Scott IU et al. Assessment of vision-related function in patients with age-related macular degeneration. Ophthalmology109(4), 720–729 (2002).
  • Riusala A, Sarna S, Immonen I. Visual function index (VF-14) in exudative age-related macular degeneration of long duration. Am. J. Ophthalmol.135(2), 206–212 (2003).
  • McKee M, Whatling JM, Wilson JL, Vallance-Owen A. Comparing outcomes of cataract surgery: challenges and opportunities. J. Public Health (Oxf.)27(4), 348–352 (2005).
  • Massof RW, Fletcher DC. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision. Vision Res.41(3), 397–413 (2001).
  • Rossi GC, Milano G, Tinelli C. The Italian version of the 25-item National Eye Institute Visual Function Questionnaire: translation, validity, and reliability. J. Glaucoma12(3), 213–220 (2003).
  • Toprak AB, Eser E, Guler C, Baser FE, Mayali H. Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol.12(4), 259–269 (2005).
  • Suzukamo Y, Oshika T, Yuzawa M et al. Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health Qual. Life Outcomes3, 65 (2005).
  • Globe D, Varma R, Azen SP, Paz S, Yu E, Preston-Martin S (Los Angeles Latino Eye Study Group). Psychometric performance of the NEI VFQ-25 in visually normal Latinos: the Los Angeles Latino Eye Study. Invest. Ophthalmol. Vis. Sci.44(4), 1470–1478 (2003).
  • Broman AT, Munoz B, West SK et al. Psychometric properties of the 25-item NEI-VFQ in a Hispanic population: Proyecto VER. Invest. Ophthalmol. Vis. Sci.42(3), 606–613 (2001).
  • Paz SH, Globe DR, Wu J, Azen SP, Varma R (Los Angeles Latino Eye Study). Relationship between self-reported depression and self-reported visual function in Latinos. Arch. Ophthalmol.121(7), 1021–1027 (2003).
  • Globe DR, Wu J, Azen SP, Varma R (Los Angeles Latino Eye Study Group). The impact of visual impairment on self-reported visual functioning in Latinos: The Los Angeles Latino Eye Study. Ophthalmology111(6), 1141–1149 (2004).
  • Magacho L, Lima FE, Nery AC, Sagawa A, Magacho B, Avila MP. Quality of life in glaucoma patients: regression analysis and correlation with possible modifiers. Ophthalmic. Epidemiol.11(4), 263–270 (2004).
  • Nordmann JP, Viala M, Sullivan K, Arnould B, Berdeaux G. Psychometric Validation of the National Eye Institute Visual Function Questionnaire – 25 (NEI VFQ-25) French version: in a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics22(3), 197–206 (2004).
  • Scilley K, DeCarlo DK, Wells J, Owsley C. Vision-specific health-related quality of life in age-related maculopathy patients presenting for low vision services. Ophthalmic. Epidemiol.11(2), 131–146 (2004).
  • Clemons TE, Chew EY, Bressler SB, McBee W (Age-Related Eye Disease Study Research Group). National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch. Ophthalmol.121(2), 211–217 (2003).
  • Miskala PH, Hawkins BS, Mangione CM et al. (The Submacular Surgery Trials Research Group) Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization – SST Report No. 1. Arch. Ophthalmol.121(4), 531–539 (2003).
  • Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14. Arch. Ophthalmol.123(9), 1207–1214 (2005).
  • Miskala PH, Bressler NM, Meinert CL. Is adjustment of National Eye Institute Visual Function Questionnaire scores for general health necessary in randomized trials? Am. J. Ophthalmol.137(5), 961–963 (2004).
  • Miskala PH, Bressler NM, Meinert CL. Relative contributions of reduced vision and general health to NEI-VFQ scores in patients with neovascular age-related macular degeneration. Arch. Ophthalmol.122(5), 758–766 (2004).
  • Owsley C, McGwin G Jr. Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology111(12), 2259–2264 (2004).
  • Walline JJ, Bailey MD, Zadnik K. Vision-specific quality of life and modes of refractive error correction. Optom. Vis. Sci.77(12), 648–652 (2000).
  • Cusick M, SanGiovanni JP, Chew EY et al. Central visual function and the NEI-VFQ-25 near and distance activities subscale scores in people with type 1 and 2 diabetes. Am. J. Ophthalmol.139(6), 1042–1050 (2005).
  • Vitale S, Goodman LA, Reed GF, Smith JA. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjogren's syndrome-related dry eye. Health Qual. Life. Outcomes2, 44 (2004).
  • Nichols KK, Mitchell GL, Zadnik K. Performance and repeatability of the NEI-VFQ-25 in patients with dry eye. Cornea21(6), 578–583 (2002).
  • Stelmack JA, Stelmack TR, Massof RW. Measuring low-vision rehabilitation outcomes with the NEI VFQ-25. Invest. Ophthalmol. Vis. Sci.43(9), 2859–2868 (2002).
  • Cole SR, Beck RW, Moke PS, Gal RL, Long DT. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest. Ophthalmol. Vis. Sci.41(5), 1017–1021 (2000).
  • Mangione CM, Phillips RS, Seddon JM et al. Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Med. Care30(12), 1111–1126 (1992).
  • Pesudovs K, Garamendi E, Keeves JP, Elliott DB. The Activities of Daily Vision Scale for cataract surgery outcomes: re-evaluating validity with Rasch analysis. Invest. Ophthalmol. Vis. Sci.44(7), 2892–2899 (2003).
  • Hart PM, Chakravarthy U, Stevenson MR, Jamison JQ. A vision specific functional index for use in patients with age related macular degeneration. Br. J. Ophthalmol.83(10), 1115–1120 (1999).
  • Hart PM, Stevenson MR, Montgomery AM, Muldrew KA, Chakravarthy U. Further validation of the Daily Living Tasks Dependent on Vision: identification of domains. Br. J. Ophthalmol.89(9), 1127–1130 (2005).
  • Schmier JK, Halpern MT, Covert D. Validation of the Daily Living Tasks Dependent on Vision (DLTV) questionnaire in a U.S. population with age-related macular degeneration. Ophthalmic. Epidemiol.13(2), 137–143 (2006).
  • McClure ME, Hart PM, Jackson AJ, Stevenson MR, Chakravarthy U. Macular degeneration: do conventional measurements of impaired visual function equate with visual disability? Br. J. Ophthalmol.84(3), 244–250 (2000).
  • Lundstrom M, Roos P, Jensen S, Fregell G. Catquest questionnaire for use in cataract surgery care: description, validity, and reliability. J. Cataract Refract. Surg.23(8), 1226–1236 (1997).
  • Kobelt G, Lundstrom M, Stenevi U. Cost-effectiveness of cataract surgery. Method to assess cost-effectiveness using registry data. J. Cataract Refract. Surg.28(10), 1742–1749 (2002).
  • Prager T, Chuang A, Slater CH, Glasser JH, Ruiz RS (The Cataract Outcome Study Group). Health related quality of life assessment in cataract populations – the Houston Vision Assessment Test (HVAT). Invest. Ophthalmol. Vis. Sci.36, S841 (1995).
  • Prager TC, Chuang AZ, Slater CH, Glasser JH, Ruiz RS. The Houston Vision Assessment Test (HVAT): an assessment of validity. The Cataract Outcome Study Group. Ophthalmic. Epidemiol.7(2), 87–102 (2000).
  • Globe DR, Levin S, Chang TS, Mackenzie PJ, Azen S. Validity of the SF-12 quality of life instrument in patients with retinal diseases. Ophthalmology109(10), 1793–1798 (2002).
  • Childs AL. Effect of order of administration of vision-related quality of life interview instruments on responses. Qual. Life Res.14(2), 493–500 (2005).
  • Bunnag C, Leurmarnkul W, Jareoncharsri P, Tunsuriyawong P, Assanasen P, Pawankar R. Quality of life assessment in Thai patients with allergic rhinoconjunctivitis using the SF-36 questionnaire (Thai version). Rhinology43(2), 99–103 (2005).
  • Childs AL (Submacular Surgery Trials Patient-Centered Outcomes Subcommittee for the Submacular Surgery Trials Pilot Study Investigators). Responsiveness of the SF-36 health survey to changes in visual acuity among patients with subfoveal choroidal neovascularization. Am. J. Ophthalmol.137(2), 373–375 (2004).
  • Mitchell J, Bradley C. Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease. Qual. Life Res.10(5), 465–473 (2001).
  • de Boer MR, de Vet HC, Terwee CB, Moll AC, Volker-Dieben HJ, van Rens GH. Changes to the subscales of two vision-related quality of life questionnaires are proposed. J. Clin. Epidemiol.58(12), 1260–1268 (2005).
  • de Boer MR, Terwee CB, de Vet HC, Moll AC, Volker-Dieben HJ, van Rens GH. Evaluation of cross-sectional and longitudinal construct validity of two vision-related quality of life questionnaires: the LVQoL and VCM1. Qual. Life Res.15(2), 233–248 (2006).
  • Frost NA, Sparrow JM, Hopper CD, Peters TJ. Reliability of the VCM1 Questionnaire when administered by post and by telephone. Ophthalmic. Epidemiol.8(1), 1–11 (2001).
  • Vitale S, Schein OD, Meinert CL, Steinberg EP. The refractive status and vision profile: a questionnaire to measure vision-related quality of life in persons with refractive error. Ophthalmology107(8), 1529–1539 (2000).
  • Schein OD. The measurement of patient-reported outcomes of refractive surgery: the refractive status and vision profile. Trans. Am. Ophthalmol. Soc.98, 439–469 (2000).
  • Nichols JJ, Mitchell GL, Zadnik K. The performance of the refractive status and vision profile survey in a contact lens clinical trial. Ophthalmology108(6), 1160–1166 (2001).
  • Garamendi E, Pesudovs K, Stevens MJ, Elliott DB. The Refractive Status and Vision Profile: evaluation of psychometric properties and comparison of Rasch and summated Likert-scaling. Vision Res.46(8–9), 1375–1383 (2006).
  • Brunette I, Gresset J, Boivin J-F, Boisjoly H, Makni H. Functional outcome and satisfaction after photorefractive keratectomy. Part 1: development and validation of a survey questionnaire. Ophthalmology107(9), 1783–1789 (2000).
  • Brunette I, Gresset J, Boivin J-F et al. Functional outcome and satisfaction after photorefractive keratectomy. Part 2: survey of 690 patients. Ophthalmology107(9), 1790–1796 (2000).
  • Nichols JJ, Mitchell GL, Saracino M, Zadnik K. Reliability and validity of refractive error-specific quality-of-life instruments. Arch. Ophthalmol.121(9), 1289–1296 (2003).
  • Ritchey ER, Barr JT, Mitchell GL. The comparison of overnight lens modalities (COLM) study. Eye Contact Lens31(2), 70–75 (2005).
  • Chan CW, Wong JC, Chan KS, Wong WK, Tam KC, Chau PS. Evaluation of quality of life in patients with cataract in Hong Kong. J. Cataract Refract. Surg.29(9), 1753–1760 (2003).
  • Donovan JL, Brookes ST, Laidlaw DA, Hopper CD, Sparrow JM, Peters TJ. The development and validation of a questionnaire to assess visual symptoms/dysfunction and impact on quality of life in cataract patients: the Visual Symptoms and Quality of life (VSQ) Questionnaire. Ophthalmic. Epidemiol.10(1), 49–65 (2003).
  • Pesudovs K, Garamendi E, Elliott DB. The Quality of Life Impact of Refractive Correction (QIRC) Questionnaire: development and validation. Optom. Vis. Sci.81(10), 769–777 (2004).
  • Pesudovs K, Garamendi E, Elliott DB. A quality of life comparison of people wearing spectacles or contact lenses or having undergone refractive surgery. J. Refract. Surg.22(1), 19–27 (2006).
  • Aslam TM, Gilmour D, Hopkinson S, Patton N, Aspinall P. The development and assessment of a self-perceived quality of vision questionnaire to test pseudophakic patients. Ophthalmic. Epidemiol.11(3), 241–253 (2004).
  • Murthy GV, Gupta SK, Thulasiraj RD, Viswanath K, Donoghue EM, Fletcher AE. The development of the Indian vision function questionnaire: questionnaire content. Br. J. Ophthalmol.89(4), 498–503 (2005).
  • Gupta SK, Viswanath K, Thulasiraj RD et al. The development of the Indian vision function questionnaire: field testing and psychometric evaluation. Br. J. Ophthalmol.89(5), 621–627 (2005).
  • Nelson P, Aspinall P, Papasouliotis O, Worton B, O’Brien C. Quality of life in glaucoma and its relationship with visual function. J. Glaucoma12(2), 139–150 (2003).
  • Erickson DB, Stapleton F, Erickson P, du Toit R, Giannakopoulos E, Holden B. Development and validation of a multidimensional quality-of-life scale for myopia. Optom. Vis. Sci.81(2), 70–81 (2004).
  • Hassell JB, Weih LM, Keeffe JE. A measure of handicap for low vision rehabilitation: the impact of vision impairment profile. Clin. Experiment. Ophthalmol.28(3), 156–161 (2000).
  • Weih LM, Hassell JB, Keeffe J. Assessment of the impact of vision impairment. Invest. Ophthalmol. Vis. Sci.43(4), 927–935 (2002).
  • Lamoureux EL, Hassell JB, Keeffe JE. The determinants of participation in activities of daily living in people with impaired vision. Am. J. Ophthalmol.137(2), 265–270 (2004).
  • Hassell JB, Lamoureux EL, Keeffe JE. Impact of age related macular degeneration on quality of life. Br. J. Ophthalmol.90(5), 593–596 (2006).
  • Mitchell J, Bradley C. Design of an individualised measure of the impact of macular disease on quality of life (the MacDQoL). Qual. Life Res.13(6), 1163–1175 (2004).
  • Mitchell J, Wolffsohn JS, Woodcock A et al. Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health Qual. Life Outcomes3, 25 (2005).
  • Woodcock A, Bradley C, Plowright R, Ffytche T, Kennedy-Martin T, Hirsch A. The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL. Patient Educ. Couns.53(3), 365–383 (2004).
  • Fraenkel G, Comaish F, Lawless MA et al. Development of a questionnaire to assess subjective vision score in myopes seeking refractive surgery. J. Refract. Surg.20(1), 10–19 (2004).
  • Wolffsohn JS, Cochrane AL, Watt NA. Implementation methods for vision related quality of life questionnaires. Br. J. Ophthalmol.84(9), 1035–1040 (2000).
  • Wolffsohn JS, Cochrane AL. Design of the low vision quality-of-life questionnaire (LVQoL) and measuring the outcome of low-vision rehabilitation. Am. J. Ophthalmol.130(6), 793–802 (2000).
  • Zou H, Zhang X, Xu X, Bai L, Wolffsohn JS. Development and psychometric tests of the Chinese-version Low Vision Quality of Life Questionnaire. Qual. Life Res.14(6), 1633–1639 (2005).
  • Owsley C, McGwin G Jr, Scilley K, Kallies K. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. Invest. Ophthalmol. Vis. Sci.47(2), 528–535 (2006).
  • Lee J, Lee J, Park K, Cho W, Kim JY, Kang HY. Assessing the value of laser in situ keratomileusis by patient-reported outcomes using quality of life assessment. J. Refract. Surg.21(1), 59–71 (2005).
  • Felius J, Stager DR Sr, Berry PM et al. Development of an instrument to assess vision-related quality of life in young children. Am. J. Ophthalmol.138(3), 362–372 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.